Charles River Laboratories CRL Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's accounts receivable, credit loss expense (reversal)?
- Charles River Laboratories (CRL) reported accounts receivable, credit loss expense (reversal) of $47K in Q1 2026.
- How has Charles River Laboratories's accounts receivable, credit loss expense (reversal) changed year-over-year?
- Charles River Laboratories's accounts receivable, credit loss expense (reversal) decreased by 97.7% year-over-year, from $2.01M to $47K.
- What is the long-term trend for Charles River Laboratories's accounts receivable, credit loss expense (reversal)?
- Over 4 years (2021 to 2025), Charles River Laboratories's accounts receivable, credit loss expense (reversal) has grown at a 38.3% compound annual growth rate (CAGR), from $1.66M to $6.06M.